New vLife™ 4.0 Focuses on Key Therapies and Platform AI Methodologies to Ease Restarting Operations After Shutdown vLife incorporates more than 500 AI-based technologies from Virtusa and partners SOUTHBOROUGH, Mass., June 09, 2020 (GLOBE NEWSWIRE) — Virtusa Corporation (NASDAQ GS: VRTU), a global provider of digital strategy, digital engineering, and IT services and solutions that help clients change […]

Read More

SAN DIEGO, June 09, 2020 (GLOBE NEWSWIRE) — Crown Bioscience today announced the presentation of new, proprietary NAFLD/NASH preclinical model development data. The data will be available at the American Diabetes Association (ADA) 80th Scientific Sessions, as well as CrownBio’s own complementary virtual event. The new data shares development of NAFLD/NASH models generated through dietary […]

Read More

New TPIR-785NIR Raman system ideal for biology, medical research and life science Teledyne Princeton Instruments’ TPIR-785 Raman spectrometer TRENTON, N.J, June 09, 2020 (GLOBE NEWSWIRE) — Teledyne Princeton Instruments, a Teledyne Technologies [NYSE:TDY] company,  and world-renowned manufacturer of scientific imaging and spectroscopy equipment, is pleased to introduce its new TPIR-785 Raman spectrometer, a fully integrated […]

Read More

GAITHERSBURG, Md., June 08, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that Gregory M. Glenn, M.D., President of Research and Development, will join other vaccine industry leaders for a panel discussion at 2020 BIO Digital. Taking place on Tuesday, June 9 […]

Read More

Proven Ag and Tech Leader to Drive Photogenics Company’s Continued Product Development Efforts and Global Growth NEW YORK and PALMERSTON NORTH, New Zealand, June 08, 2020 (GLOBE NEWSWIRE) — BioLumic Ltd. (“BioLumic”), the leader in using plant photogenics to unlock the genetic potential of seeds and seedlings, today announced the appointment of Steve Sibulkin as […]

Read More

Helsinn announces FDA acceptance of IND application for TAS0953/HM06 in Patients with Advanced Solid Tumors with RET Gene Abnormalities Lugano, Switzerland, June 8, 2020: Helsinn, a Swiss pharmaceutical group focused on building quality cancer care and rare diseases products, today announced that on April 1, 2020 the U.S. Food and Drug Administration (FDA) completed the […]

Read More

Global automotive innovator drives IP lifecycle efficiencies through Anaqua software and services BOSTON, June 08, 2020 (GLOBE NEWSWIRE) — Anaqua, the leading provider of innovation and intellectual property management solutions, today announced that General Motors (GM) has selected Anaqua to help manage its extensive global patent and design portfolio. Through the agreement, GM will leverage […]

Read More